Finzati - Logo
INDP logo

Indaptus Therapeutics, Inc.

INDP • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$106.01M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 1.51Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$106.01M
52W Range0.92 - 8.57
Beta1.18
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio1.51
Quick Ratio1.51
Volume332.38K

Investment DNA

How strong this company looks for long-term investors

46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
64/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 1.51Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/4/2015
Industry: Biotechnology
P/B i: 0.89
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.00
Current Ratio: 1.51
Quick Ratio: 1.51
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Lu Qinglai
Transaction: 04/08/2026
OTHER
Change
0
Price
Not reported
Filing
04/20/2026
Type
OTHER
Dai Junyi
Transaction: 03/23/2026
OTHER
Change
0
Price
Not reported
Filing
04/02/2026
Type
OTHER
SINO LION VENTURES Ltd
Transaction: 03/23/2026
OTHER
Change
0
Price
Not reported
Filing
04/02/2026
Type
OTHER